Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
37.04B
Market cap37.04B
Price-Earnings ratio
26.23
Price-Earnings ratio26.23
Dividend yield
0.78%
Dividend yield0.78%
Average volume
2.30M
Average volume2.30M
High today
High today
Low today
Low today
Open price
$132.02
Open price$132.02
Volume
0.00
Volume0.00
52 Week high
$160.27
52 Week high$160.27
52 Week low
$108.35
52 Week low$108.35

Stock Snapshot

With a market cap of 37.04B, Agilent(A) trades at $133.00. The stock has a price-to-earnings ratio of 26.23 and currently yields dividends of 0.78%.

On 2026-07-08, Agilent(A) shares started trading at $132.02, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.3M.

The stock's 52-week range extends from a low of $108.35 to a high of $160.27.

The stock's 52-week range extends from a low of $108.35 to a high of $160.27.

A News

TipRanks 2d
Agilent price target raised to $148 from $144 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Agilent (A) to $148 from $144 and keeps an Outperform rating on the shares. The firm’s Q2 pre...

Simply Wall St 3d
Agilent Launches AI Cell Imaging Software For Biopharma Research

Agilent Technologies (NYSE:A) has released an AI powered xCELLigence RTCA eSight AI software module for biopharma research. The upgrade is designed to automate...

Agilent Launches AI Cell Imaging Software For Biopharma Research

Analyst ratings

78%

of 23 ratings
Buy
78.3%
Hold
21.7%
Sell
0%

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.